Category : Seaking Alpha

Waterpoint Lane Welcomes Michael Vranos, CEO of Ellington Management Group, as Strategic Advisor

NEW YORK, Nov. 26, 2024 /PRNewswire/ -- Waterpoint Lane, a venture capital firm at the forefront of sustainable agrifoodtech innovation, proudly announces the addition of Michael Vranos, founder and CEO of Ellington Management Group, as Strategic Adv...

Evolv Technologies settles FTC complaint on accuracy of weapons detection system

AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY

MariTide Demonstrated up to ~20% Average Weight Loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight MariTide is the First Obesity Treatment With Monthly or Less Frequent Dosing to Demonstrate Safe and Effective...

Analog Devices Reports Fourth Quarter and Fiscal 2024 Financial Results

Fourth quarter revenue of more than $2.4 billion, above the midpoint of guidance with sequential growth across all end markets Fiscal 2024 revenue of more than $9.4 billion Fiscal 2024 operating cash flow of $3.9 billion and free cash flow of $3.1 bi...

Exyte Receives Micron's Outstanding Supplier Performance Award in Supplier Diversity

STUTTGART, Germany, Nov. 26, 2024 /PRNewswire/ -- Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, was presented with the Outstanding Supplier Performance Award in Supplier Diversity at the Micron Supplier Day...

DICK'S Sporting Goods Reports Third Quarter Results

– Delivers 4.2% Comparable Sales Growth – – Raises 2024 Comp Sales and EPS Outlook – Delivered third quarter net sales of $3.06 billion and earnings per diluted share of $2.75 including the expected unfavorable impact from the calendar shift of appro...

Thomas Belcher Joins Capital Square as Senior Regional Vice President, Northwest Sales

RICHMOND, Va., Nov. 26, 2024 /PRNewswire/ -- Capital Square, one of the nation's leading sponsors of tax-advantaged real estate investments and an active developer and manager of housing communities, announced today that Thomas Belcher has joined the...

UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual Meeting

32 scientific abstracts reflect ongoing commitment to improving outcomes for people living with epilepsies Data include the use of FINTEPLA® (fenfluramine)1 oral solution in seizures associated with Dravet syndrome and Lennox-Gastaut syndrome, BRIVIA...

Viper Partners Facilitates a New Era in Aesthetic Care: Ridha Plastic Surgery & Medspa Joins Princeton Medspa Partners

PALM BEACH, Fla., Nov. 26, 2024 /PRNewswire/ -- In a transformative move executed by Viper Equity Partners, a leader in healthcare investment banking, Ridha Plastic Surgery & Medspa has joined forces with Princeton Medspa Partners. This strategic...

W-Cycle and Melhoramentos Join Forces to Produce Compostable Food Containers

The Clean-tech company to share tech with Melhoramentos for producing next-generation high-performance pulp-fiber packaging GAN SHMUEL, Israel, Nov. 26, 2024 /PRNewswire/ -- W-Cycle, Ltd., an innovator in sustainable food packaging, and Melhoramentos...

Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility

NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB, Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis co...

Brenig Therapeutics Announces the Initiation of First-in-Human Clinical Trial of BT-267, a Best-in-Class LRRK2 Inhibitor for Parkinson's Disease

DOVER, Del., Nov. 26, 2024 /PRNewswire/ -- Brenig Therapeutics announced the initiation of the first-in-human clinical trial for BT-267, a best-in-class LRRK2 inhibitor developed as a potential disease-modifying treatment for idiopathic and LRRK2-ass...

SystImmune, Inc. Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting

Initial results from a First-In-Human Ph1 study in relapsed refractory Acute Myeloid Leukemia (AML) patients treated with BL-M11D1, a novel CD33 antibody-drug conjugate (ADC) REDMOND, Wash., Nov. 26, 2024 /PRNewswire/ -- SystImmune, Inc. (SystImmune)...

NANUK announces the appointment of a new Vice President to accelerate the development of its commercial division and global strategic markets

MONTREAL, Nov. 26, 2024 /PRNewswire/ - NANUK Equipment Protection Inc. continues its ambitious growth trajectory by announcing the appointment of Ed Meyer as Vice President, Global Business Development and Strategic Markets, effective January 6, 2025...

The J.M. Smucker Co. Announces Fiscal 2025 Second Quarter Results

ORRVILLE, Ohio, Nov. 26, 2024 /PRNewswire/ -- The J.M. Smucker Co. (NYSE: SJM) today announced results for the second quarter ended October 31, 2024, of its 2025 fiscal year. Financial results for the second quarter of fiscal year 2025 reflect the di...